Nampoothiri, S. Et Al. 2019. Does the clinical phenotype of mucolipidosis-III gamma differ from its alpha beta counterpart?: supporting facts in a cohort of 18 patients. CLINICAL DYSMORPHOLOGY , vol.28, no.1 , 7-16.

Nampoothiri, S., Elcioglu, N. H., KOCA, S. S., Yesodharan, D., Chandrababu, K. K., Vinod, K. V., ... Bhat, M.(2019). Does the clinical phenotype of mucolipidosis-III gamma differ from its alpha beta counterpart?: supporting facts in a cohort of 18 patients. CLINICAL DYSMORPHOLOGY , vol.28, no.1, 7-16.

Nampoothiri, Sheela Et Al. "Does the clinical phenotype of mucolipidosis-III gamma differ from its alpha beta counterpart?: supporting facts in a cohort of 18 patients," CLINICAL DYSMORPHOLOGY , vol.28, no.1, 7-16, 2019

Nampoothiri, Sheela Et Al. "Does the clinical phenotype of mucolipidosis-III gamma differ from its alpha beta counterpart?: supporting facts in a cohort of 18 patients." CLINICAL DYSMORPHOLOGY , vol.28, no.1, pp.7-16, 2019

Nampoothiri, S. Et Al. (2019) . "Does the clinical phenotype of mucolipidosis-III gamma differ from its alpha beta counterpart?: supporting facts in a cohort of 18 patients." CLINICAL DYSMORPHOLOGY , vol.28, no.1, pp.7-16.

@article{article, author={Sheela Nampoothiri Et Al. }, title={Does the clinical phenotype of mucolipidosis-III gamma differ from its alpha beta counterpart?: supporting facts in a cohort of 18 patients}, journal={CLINICAL DYSMORPHOLOGY}, year=2019, pages={7-16} }